BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35401460)

  • 1. The Characteristics of the HIV-1 Env Glycoprotein Are Linked With Viral Pathogenesis.
    Pérez-Yanes S; Pernas M; Marfil S; Cabrera-Rodríguez R; Ortiz R; Urrea V; Rovirosa C; Estévez-Herrera J; Olivares I; Casado C; Lopez-Galindez C; Blanco J; Valenzuela-Fernández A
    Front Microbiol; 2022; 13():763039. PubMed ID: 35401460
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Viral Characteristics Associated with the Clinical Nonprogressor Phenotype Are Inherited by Viruses from a Cluster of HIV-1 Elite Controllers.
    Casado C; Marrero-Hernández S; Márquez-Arce D; Pernas M; Marfil S; Borràs-Grañana F; Olivares I; Cabrera-Rodríguez R; Valera MS; de Armas-Rillo L; Lemey P; Blanco J; Valenzuela-Fernández A; Lopez-Galíndez C
    mBio; 2018 Apr; 9(2):. PubMed ID: 29636433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transactive Response DNA-Binding Protein (TARDBP/TDP-43) Regulates Cell Permissivity to HIV-1 Infection by Acting on HDAC6.
    Cabrera-Rodríguez R; Pérez-Yanes S; Montelongo R; Lorenzo-Salazar JM; Estévez-Herrera J; García-Luis J; Íñigo-Campos A; Rubio-Rodríguez LA; Muñoz-Barrera A; Trujillo-González R; Dorta-Guerra R; Casado C; Pernas M; Blanco J; Flores C; Valenzuela-Fernández A
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of the HIV-1 Envelope Glycoprotein to AIDS Pathogenesis and Clinical Progression.
    Valenzuela-Fernández A; Cabrera-Rodríguez R; Casado C; Pérez-Yanes S; Pernas M; García-Luis J; Marfil S; Olivares I; Estévez-Herrera J; Trujillo-González R; Blanco J; Lopez-Galindez C
    Biomedicines; 2022 Sep; 10(9):. PubMed ID: 36140273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV Progression Depends on Codon and Amino Acid Usage Profile of Envelope Protein and Associated Host-Genetic Influence.
    Roy A; Banerjee R; Basak S
    Front Microbiol; 2017; 8():1083. PubMed ID: 28663742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elite controllers long-term non progressors present improved survival and slower disease progression.
    Capa L; Ayala-Suárez R; De La Torre Tarazona HE; González-García J; Del Romero J; Alcamí J; Díez-Fuertes F
    Sci Rep; 2022 Sep; 12(1):16356. PubMed ID: 36175445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole Exome Sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules.
    Nissen SK; Christiansen M; Helleberg M; Kjær K; Jørgensen SE; Gerstoft J; Katzenstein TL; Benfield T; Kronborg G; Larsen CS; Laursen A; Pedersen G; Jakobsen MR; Tolstrup M; Mogensen TH
    Sci Rep; 2018 Oct; 8(1):15253. PubMed ID: 30323326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elite controllers and lessons learned for HIV-1 cure.
    Lopez-Galindez C; Pernas M; Casado C; Olivares I; Lorenzo-Redondo R
    Curr Opin Virol; 2019 Oct; 38():31-36. PubMed ID: 31252326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic features of the selective pressure on the human immunodeficiency virus type 1 (HIV-1) gp120 CD4-binding site in a group of long term non progressor (LTNP) subjects.
    Canducci F; Marinozzi MC; Sampaolo M; Berrè S; Bagnarelli P; Degano M; Gallotta G; Mazzi B; Lemey P; Burioni R; Clementi M
    Retrovirology; 2009 Jan; 6():4. PubMed ID: 19146663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential prevalence of the HLA-C -- 35 CC genotype among viremic long term non-progressor and elite controller HIV+ individuals.
    Ballana E; Ruiz-de Andres A; Mothe B; Ramirez de Arellano E; Aguilar F; Badia R; Grau E; Clotet B; del Val M; Brander C; Esté JA
    Immunobiology; 2012 Sep; 217(9):889-94. PubMed ID: 22333575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyfunctional Fc Dependent Activity of Antibodies to Native Trimeric Envelope in HIV Elite Controllers.
    Kant S; Zhang N; Barbé A; Routy JP; Tremblay C; Thomas R; Szabo J; Côté P; Trottier B; LeBlanc R; Rouleau D; Harris M; Dupuy FP; Bernard NF
    Front Immunol; 2020; 11():583820. PubMed ID: 33101312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elite suppressor-derived HIV-1 envelope glycoproteins exhibit reduced entry efficiency and kinetics.
    Lassen KG; Lobritz MA; Bailey JR; Johnston S; Nguyen S; Lee B; Chou T; Siliciano RF; Markowitz M; Arts EJ
    PLoS Pathog; 2009 Apr; 5(4):e1000377. PubMed ID: 19360131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporal relationship between V1V2 variation, macrophage replication, and coreceptor adaptation during HIV-1 disease progression.
    Masciotra S; Owen SM; Rudolph D; Yang C; Wang B; Saksena N; Spira T; Dhawan S; Lal RB
    AIDS; 2002 Sep; 16(14):1887-98. PubMed ID: 12351948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Highly Unusual V1 Region of Env in an Elite Controller of HIV Infection.
    Silver ZA; Dickinson GM; Seaman MS; Desrosiers RC
    J Virol; 2019 May; 93(10):. PubMed ID: 30842322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rare mutations in a domain crucial for V3-loop structure prevail in replicating HIV from long-term non-progressors.
    Menzo S; Sampaolesi R; Vicenzi E; Santagostino E; Liuzzi G; Chirianni A; Piazza M; Cohen OJ; Bagnarelli P; Clementi M
    AIDS; 1998 Jun; 12(9):985-97. PubMed ID: 9662194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host and viral genetic correlates of clinical definitions of HIV-1 disease progression.
    Casado C; Colombo S; Rauch A; Martínez R; Günthard HF; Garcia S; Rodríguez C; Del Romero J; Telenti A; López-Galíndez C
    PLoS One; 2010 Jun; 5(6):e11079. PubMed ID: 20552027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of HIV non-progression; robust and sustained CD4+ T-cell proliferative responses to p24 antigen correlate with control of viraemia and lack of disease progression after long-term transfusion-acquired HIV-1 infection.
    Dyer WB; Zaunders JJ; Yuan FF; Wang B; Learmont JC; Geczy AF; Saksena NK; McPhee DA; Gorry PR; Sullivan JS
    Retrovirology; 2008 Dec; 5():112. PubMed ID: 19077215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breadth of HIV-1 Env-specific antibody-dependent cellular cytotoxicity: relevance to global HIV vaccine design.
    Madhavi V; Wren LH; Center RJ; Gonelli C; Winnall WR; Parsons MS; Kramski M; Kent SJ; Stratov I
    AIDS; 2014 Aug; 28(13):1859-70. PubMed ID: 24937308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors.
    Díez-Fuertes F; De La Torre-Tarazona HE; Calonge E; Pernas M; Alonso-Socas MDM; Capa L; García-Pérez J; Sakuntabhai A; Alcamí J
    Sci Rep; 2019 Oct; 9(1):14265. PubMed ID: 31582776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV-1 envelope glycoproteins isolated from Viremic Non-Progressor individuals are fully functional and cytopathic.
    Cabrera-Rodríguez R; Hebmann V; Marfil S; Pernas M; Marrero-Hernández S; Cabrera C; Urrea V; Casado C; Olivares I; Márquez-Arce D; Pérez-Yanes S; Estévez-Herrera J; Clotet B; Espert L; López-Galíndez C; Biard-Piechaczyk M; Valenzuela-Fernández A; Blanco J
    Sci Rep; 2019 Apr; 9(1):5544. PubMed ID: 30944395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.